Dow Down 1.17% Nasdaq Down 1.19%

More On GRFS

Grifols, S.A. (GRFS)

-NasdaqGS
15.77 Apr 28, 3:59PM EDT
Prev Close:15.77
Open:N/A
Bid:15.70 x 100
Ask:15.78 x 1000
1y Target Est:17.00
Beta:1.01846
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:14.07 - 18.04
Volume:0
Avg Vol (3m):1,403,310
Market Cap:21.56B
P/E (ttm):35.88
EPS (ttm):0.44
Div & Yield:0.38 (2.40%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):13.03
P/S (ttm):4.85
Ex-Dividend Date:10-Dec-15

Analysts

Annual EPS Est (Dec-16) :1.09
Quarterly EPS Est (Mar-16) :0.24
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.96

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Grifols, S.A., a biopharmaceutical company, develops, manufactures, and distributes plasma derivative products in the United States, Canada, Spain, rest of the European Union, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback